Shandong province-based biologics and biopharmaceutical contract development and manufacturing organization (CDMO) MabPlex has raised RMB400 million ($59 million) in Series A funding led by SDIC Venture Capital and Shenzhen Capital Group.
Founded in 2013, MabPlex offers biologics development and manufacturing services for global drug companies from the pre-clinical stage to commercial launch. Focus areas include antibody-drug conjugates...
Apis Partners has agreed to invest up to $110 million in L&T Infra Debt Fund (L&T IDF), a subsidiary of India’s L&T Finance Holdings focused on financing infrastructure projects in India.
Omnivore Partners, an Indian venture capital firm focused on impact investment in the local agriculture industry, has closed its second early-stage fund with $97 million in commitments.
CDIB Capital has invested an undisclosed amount in VHQ China, a Taiwan-based provider of post-production and visual effects services focused on China’s film and TV drama industry.
Tongdun Technology, a Chinese risk control services provider, has raised $100 million in a new round of funding led by CMC Capital, GGV Capital, China Everbright Limited and Guotai Global Investments. Existing investor Cinda Sinorock Capital also participated.